Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Two loss years in a row NBB
Negative result in 2024 and 2025.
-
Tight liquidity NBB
Cash and receivables cover 19 % of short-term debt in 2025; threshold 65 %.
-
Busy address KBO
13 other companies have their registered office at the same address; threshold 10.
Financials
Financial year 2025
Obvio Laboratories from Ukkel, company number BE0763445923, closed financial year 2025 with a result of € -33,304 after tax. For that financial year Obvio Laboratories recorded a gross margin of € -15,896 and equity of € 2,560. Compared with financial year 2024, the result moved from € -16,233 to € -33,304. The company made a loss. The buffer shrank hard: equity is 94 % below last year. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on October 31, 2025.
€ 2,560
▼ 94% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ -33,304
▼ 105 % more loss than in 2024
Profit after tax over the fiscal year.
€ 18,587
▲ 30% vs 2024
Cash and bank balances on the last day of the fiscal year.
Loss, nothing to pay out
Reserves fell to € -63,129.
People and assets in 2025
€ 815
Book value of vehicles, furniture and equipment.
Debts at end 2025
None
No bank loans on the last day of the fiscal year.
€ 4,635
▼ 74% vs 2024
Supplier invoices still open on the last day of the fiscal year.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € -4,490 | € -3,947 | € -9,037 | € -15,896 | ▼ € 6,860 |
| Profit after taxes | € -6,220 | € -7,372 | € -16,233 | € -33,304 | ▼ € 17,071 |
| Equity | € 69,041 | € 56,168 | € 43,277 | € 2,560 | ▼ 94% |
| Total debts | € 848 | € 2,528 | € 51,122 | € 138,441 | ▲ 171% |
| Cash | € 25,746 | € 23,720 | € 14,281 | € 18,587 | ▲ 30% |
| Retained profit | € -6,220 | € -13,592 | € -29,825 | € -63,129 | ▼ € 33,304 |
| Balance sheet total | € 69,889 | € 58,696 | € 94,399 | € 141,001 | ▲ 49% |
Key figures of Obvio Laboratories, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.
What happened to Obvio Laboratories?
What happened at Obvio Laboratories in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: loss of € 33,304. Source: NBB ↗
- New establishment in Ottignies-Louvain-la-Neuve. KBO
- New establishment in Ukkel. KBO
- Start of the company according to the CBE. KBO
In short
From € 6,220 loss in 2022 to € 33,304 loss in 2025.
A new publication or filing at Obvio Laboratories? We notify you, reason included.
Follow Obvio LaboratoriesDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
Behind Obvio Laboratories are Jean François LIENART VAN LIDTH DE JEUDE and Daniel GELBGRAS.
Directors
According to the 2025 annual accounts
Jean François LIENART VAN LIDTH DE JEUDE
Director
Daniel GELBGRAS
Director
Establishments
Establishment units
Physical locations of this company
Dodonéestraat 77 box 9
1180 Ukkel
Dodonéestraat 77 A box 9
1180 Ukkel
Active since 10 February 2021
Chemin du Cyclotron 6
1348 Ottignies-Louvain-la-Neuve
Active since 15 April 2021
Who else lives here?
A building full of entrepreneurs or one very busy letterbox? Another 13 companies are registered at this address.
All companies at this address →VANHAM & VANHAM
€ 39,164 gross margin · 2025
METROPOLE - PROPERTIES
€ 107,249 gross margin · 2024
QUATRE D
€ 22,858 gross margin · 2025
AMANSAFI
€ 75,168 gross margin · 2025
IMMO HUMBLET
€ 31,533 gross margin · 2025
+8 more
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Website
Technologies
Hosting & Email
Email provider
Self-hosted
Hosting
COMBELL-AS, BE
Domain
Domain
obviolabs.com
Registered
2020-12-03
Registrar
Combell NV
Expires
2026-12-03
Website info
Features
Security
Details
- Company number
- 0763.445.923
- VAT number
- BE 0763.445.923
- Registered office
- Dodonéestraat 77 bus 9, 1180 Ukkel
- Names & denominations
- Obvio Laboratories · Obvio Labs
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 10 February 2021
- Peppol
- Active · Active since 13 Jan 2026
- Contact
- obviolabs.com [email protected] 0460948474
- Activities · NACE
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Overig speur- en ontwikkelingswerk op natuurwetenschappelijk gebied
Speur- en ontwikkelingswerk op biotechnologisch gebied
Detailhandel in ICT-apparatuur
Detailhandel in vaste, vloeibare en gasvormige brandstoffen, muv motorbrandstoffen
Detailhandel in overige sportartikelen
Overige detailhandel, niet in winkels en exclusief markt- en straathandel
Detailhandel in sport- en kampeerartikelen in gespecialiseerde winkels
+1